Hinge Health (HNGE) Short-term Investments (2024 - 2026)

Hinge Health has reported Short-term Investments for 3 years, with the latest figure at $129.2 million in Q1 2026.

• Quarterly Short-term Investments changed N/A year-over-year to $129.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $129.2 million (changed N/A YoY) and the FY2025 annual result came in at $155.9 million, down 5.98% from the prior year.
• Short-term Investments retreated to $129.2 million in Q1 2026 per HNGE's latest filing, from $155.9 million in the prior quarter.
• Over five years, Short-term Investments peaked at $218.7 million in Q3 2025 and troughed at $129.2 million in Q1 2026.
• A 3-year average of $169.1 million and a median of $165.8 million in 2024 frame the typical range for Short-term Investments.
• The widest YoY moves for Short-term Investments: up 5.98% in 2025, down 5.98% in 2025.
• Over 3 years, Short-term Investments stood at $165.8 million in 2024, then retreated by 5.98% to $155.9 million in 2025, then retreated by 17.11% to $129.2 million in 2026.
• According to Business Quant data, Short-term Investments over the past three periods registered $129.2 million, $155.9 million, and $218.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.